Program
Chickenpox Vaccine
Also written as “Varicella Vaccine”, “Investigational live attenuated varicella vaccine” and “Zoster Vaccine, Live”.
Its studies are mostly in Chickenpox · Herpes Zoster · Meningococcal Infections · Measles · Streptococcal Infections, led by 6 companies.
Drug pageChickenpox Vaccine: every studyMany companies study it; this page follows only the 43 they lead. All 76 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Merckits history only | 210 open or running | phase 4since Feb 7, 2007 | Apr 22, 2005 | none ahead |
| Sinovac Biotech | 124 open or running | phase 4since Oct 14, 2021 | Nov 14, 2016 | Dec 2028phase 4 · NCT06484686 |
| GlaxoSmithKlineits history only | 60 open or running | phase 3since Sep 13, 2005 | Sep 13, 2005 | none ahead |
| Sinopharmits history only | 22 open or running | phase 3since Dec 20, 2022 | Dec 20, 2022 | none ahead |
| Changchun Changsheng Life Science and Technologyits history only | 10 open or running | phase 4since Oct 24, 2013 | Oct 24, 2013 | none ahead |
| GC Biopharmaits history only | 10 open or running | phase 3since Nov 28, 2017 | Nov 28, 2017 | none ahead |
Also a collaborator on its studies: Beijing Institute of Biological Products.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Sinovac Biotech only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Nov 14, 2016First study: phase 1 study in ChickenpoxFirst studyNCT02965404 · 270 enrolled · China
- Nov 28, 2016Phase 3 study in ChickenpoxNCT02981836 · 5,997 enrolled · China
- Oct 14, 2021Phase 4 study in ChickenpoxNCT05095701 · 703 planned · China
- Nov 22, 2021Phase 3 study in ChickenpoxNCT05150392 · 1,193 enrolled · China
- Jul 12, 20222 phase 4 studies in ChickenpoxNCT05470855, NCT05460429
- Mar 6, 2024Phase 3 study in ChickenpoxNCT06314724 · 642 enrolled · Philippines
- Jun 26, 2024Phase 4 study in ChickenpoxNCT06484686 · 414 planned · China
- Mar 2, 2025Phase 4 study in ChickenpoxNCT06891872 · 720 planned · China
- May 15, 20252 phase 4 studiesNCT06987942, NCT06994052
- Mar 11, 2026Phase 3 study in ChickenpoxNCT07473427 · 300 planned · Vietnam
Ahead
- Dec 2028Primary completion: phase 4 study in ChickenpoxNCT06484686
TargetBeta
A vaccine: it acts on a pathogen, not a human gene.
Studies
All 12 Sinovac Biotech leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07473427Chickenpox · Vietnam | 3 | Not yet recruiting | Aug 1, 2026 | 300 |
| NCT06994052VZV · China | 4 | Completed | Nov 30, 2024 | 412 |
| NCT06987942Chickenpox · China | 4 | Completed | Nov 15, 2024 | 899 |
| NCT06891872Chickenpox · China | 4 | Not yet recruiting | Dec 2025 | 720 |
| NCT06484686Chickenpox · China | 4 | By invitation | Dec 2028 | 414 |
| NCT06314724Chickenpox · Philippines | 3 | Completed | Sep 6, 2024 | 642 |
| NCT05470855Chickenpox · China | 4 | UNKNOWN | Nov 30, 2022 | 45,400 |
| NCT05460429Chickenpox · China | 4 | UNKNOWN | Mar 15, 2023 | 37,920 |
| NCT05150392Chickenpox · China | 3 | Completed | Aug 11, 2018 | 1,193 |
| NCT05095701Chickenpox · China | 4 | By invitation | Dec 19, 2021 | 703 |
| NCT02981836Chickenpox · China | 3 | Completed | Jun 2017 | 5,997 |
| NCT02965404Chickenpox · China | 1 | Completed | May 2016 | 270 |
How it is read
Names in the registry
- “Varicella Vaccine”, 4 entries
- “Investigational live attenuated varicella vaccine”, 4 entries
- “Zoster Vaccine, Live”, 3 entries
- “Varicella Virus Vaccine Live”, 2 entries
- “Live Attenuated Varicella Vaccine”, 2 entries
Conditions, from the studies’ own filings
- Chickenpox, 24 studies
- Herpes Zoster, 15 studies
- Meningococcal Infections, 1 study
- Measles, 1 study
- Streptococcal Infections, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.